TipRanks
Advertisement
Advertisement
MGNX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMGNX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MacroGenics Advances MGC026 in Phase 1 Oncology Trial
Premium
Company Announcements
MacroGenics Advances MGC026 in Phase 1 Oncology Trial
3M ago
MacroGenics provides update on MGC026 study
Premium
The Fly
MacroGenics provides update on MGC026 study
3M ago
MacroGenics reports Q1 EPS (58c), consensus (55c)
PremiumThe FlyMacroGenics reports Q1 EPS (58c), consensus (55c)
5M ago
MacroGenics Sells Maryland Biologics Manufacturing to Bora
Premium
Company Announcements
MacroGenics Sells Maryland Biologics Manufacturing to Bora
5M ago
MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront
Premium
The Fly
MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront
5M ago
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
PremiumThe FlyMacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
6M ago
MacroGenics price target raised to $6 from $4 at Barclays
Premium
The Fly
MacroGenics price target raised to $6 from $4 at Barclays
6M ago
MacroGenics Nears Key Prostate Cancer Catalyst as Phase 2 Lorigerlimab Trial Completes
Premium
Company Announcements
MacroGenics Nears Key Prostate Cancer Catalyst as Phase 2 Lorigerlimab Trial Completes
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―